Position in MRK
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$70,951,917
+$3,361,929 QoQ
Shares Held
552,155
-1.7% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
1.05%
of 13F equity value
Holder Rank
#255
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Douglas Lane & Associates, LLC holds $414,684,195 across 11 Drug Manufacturers - General names. MRK ranks #3 (17.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
663,667 | $168,551,507 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
1,556,184 | $89,667,322 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
552,155 | $70,951,917 | |
| 4 | GSK |
GSK plc
|
946,636 | $49,622,659 | |
| 5 | NVS |
Novartis AG
|
140,152 | $21,964,621 | |
| 6 | AMGN |
Amgen Inc
|
13,032 | $4,719,147 | |
| 7 | LLY |
ELI LILLY & Co
|
2,861 | $3,431,569 | |
| 8 | ABBV |
AbbVie Inc.
|
9,961 | $2,506,586 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $70,951,917 | 552,155 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $67,589,988 | 561,892 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $59,559,160 | 565,829 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $45,267,645 | 539,350 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $41,155,363 | 519,901 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $45,904,610 | 511,415 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $51,688,713 | 519,589 | Shares | Sole | 2025-01-08 | |
| 2024-09-30 | $57,143,051 | 503,197 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $63,297,949 | 511,292 | Shares | Sole | 2024-07-08 | |
| 2024-03-31 | $69,569,977 | 527,245 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $54,889,389 | 503,480 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $51,715,697 | 502,338 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $58,634,620 | 508,143 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $55,700,271 | 523,548 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $59,705,745 | 538,132 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $49,033,799 | 569,366 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $52,264,843 | 573,268 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $47,547,564 | 579,495 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $44,702,655 | 583,281 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $42,664,883 | 568,032 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $40,615,926 | 522,257 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $37,407,094 | 485,239 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $37,917,145 | 463,535 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $38,539,168 | 464,607 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $34,918,454 | 451,551 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $34,586,285 | 449,523 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||